誘導治療での高投与量シタラビンは46歳より若い急性骨髄性白血病成人患者の転帰を改善する: EORTC-GIMEMA AML-12試験
Willemze Roelof,Suciu Stefan,Meloni Giovanna,Labar Boris,Marie Jean-Pierre,J M Halkes Constantijn,Muus Petra,Mistrik Martin,Amadori Sergio,Specchia Giorgina,Fabbiano Francesco,Nobile Francesco,Sborgia Marco,Camera Andrea, L D Selleslag Dominik,Lefrere Francois,Magro Domenico,Sica Simona,Cantore Nicola,Beksac Meral,Berneman Zwi,Thomas Xavier,Melillo Lorella,E Guimaraes Jose,Leoni Pietro,Luppi Mario,E Mitra Maria,Bron Dominique,Fillet Georges,W A Marijt Erik,Venditti Adriano,Hagemeijer Anne,Mancini Marco,Jansen Joop,Cilloni Daniela,Meert Liv,Fazi Paola,Vignetti Marco,M Trisolini Silvia Journal of Clinical Oncology(2014)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper